169 related articles for article (PubMed ID: 34673003)
1. Brucella antigens (BhuA, 7α-HSDH, FliC) in poly I:C adjuvant as potential vaccine candidates against brucellosis.
Sadeghi Z; Fasihi-Ramandi M; Bouzari S
J Immunol Methods; 2022 Jan; 500():113172. PubMed ID: 34673003
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle-Based Vaccines for Brucellosis: Calcium Phosphate Nanoparticles-Adsorbed Antigens Induce Cross Protective Response in Mice.
Sadeghi Z; Fasihi-Ramandi M; Bouzari S
Int J Nanomedicine; 2020; 15():3877-3886. PubMed ID: 32581535
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of immunogenicity of novel multi-epitope subunit vaccines in combination with poly I:C against Brucella melitensis and Brucella abortus infection.
Sadeghi Z; Fasihi-Ramandi M; Bouzari S
Int Immunopharmacol; 2019 Oct; 75():105829. PubMed ID: 31437796
[TBL] [Abstract][Full Text] [Related]
4. A combined subunit vaccine comprising BP26, Omp25 and L7/L12 against brucellosis.
Gupta S; Singh D; Gupta M; Bhatnagar R
Pathog Dis; 2019 Nov; 77(8):. PubMed ID: 31971564
[TBL] [Abstract][Full Text] [Related]
5. Immunization of BALB/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus.
Hop HT; Arayan LT; Huy TXN; Reyes AWB; Min W; Lee HJ; Park SJ; Chang HH; Kim S
Vaccine; 2018 May; 36(21):3027-3033. PubMed ID: 29678458
[TBL] [Abstract][Full Text] [Related]
6. Recombinant outer membrane protein 25c from Brucella abortus induces Th1 and Th2 mediated protection against Brucella abortus infection in mouse model.
Paul S; Peddayelachagiri BV; Nagaraj S; Kingston JJ; Batra HV
Mol Immunol; 2018 Jul; 99():9-18. PubMed ID: 29649688
[TBL] [Abstract][Full Text] [Related]
7. Mannosylated chitosan nanoparticles loaded with FliC antigen as a novel vaccine candidate against Brucella melitensis and Brucella abortus infection.
Sadeghi Z; Fasihi-Ramandi M; Azizi M; Bouzari S
J Biotechnol; 2020 Feb; 310():89-96. PubMed ID: 32017955
[TBL] [Abstract][Full Text] [Related]
8. Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats.
Mailybayeva A; Yespembetov B; Ryskeldinova S; Zinina N; Sansyzbay A; Renukaradhya GJ; Petrovsky N; Tabynov K
PLoS One; 2017; 12(10):e0186484. PubMed ID: 29023541
[TBL] [Abstract][Full Text] [Related]
9. Studies on recombinant glucokinase (r-glk) protein of Brucella abortus as a candidate vaccine molecule for brucellosis.
Vrushabhendrappa ; Singh AK; Balakrishna K; Sripathy MH; Batra HV
Vaccine; 2014 Sep; 32(43):5600-6. PubMed ID: 25131740
[TBL] [Abstract][Full Text] [Related]
10. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and protective efficacy of Brucella abortus recombinant protein cocktail (rOmp19+rP39) against B. abortus 544 and B. melitensis 16M infection in murine model.
Tadepalli G; Singh AK; Balakrishna K; Murali HS; Batra HV
Mol Immunol; 2016 Mar; 71():34-41. PubMed ID: 26826463
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal administration of a novel chimeric immunogen (rOP) elicits IFN-γ and IL-12p70 protective immune response in BALB/c mice against virulent Brucella.
Tadepalli G; Konduru B; Murali HS; Batra HV
Immunol Lett; 2017 Dec; 192():79-87. PubMed ID: 29106986
[TBL] [Abstract][Full Text] [Related]
13. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
[TBL] [Abstract][Full Text] [Related]
14. Protection of mice against Brucella abortus 544 challenge by vaccination with recombinant OMP28 adjuvanted with CpG oligonucleotides.
Kaushik P; Singh DK; Kumar SV; Tiwari AK; Shukla G; Dayal S; Chaudhuri P
Vet Res Commun; 2010 Feb; 34(2):119-32. PubMed ID: 20013309
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the protective immunity elicited by a Brucella cocktail protein vaccine (rL7/L12+rTOmp31+rSOmp2b) in two different adjuvant formulations in BALB/c mice.
Golshani M; Amani M; Siadat SD; Nejati-Moheimani M; Arsang A; Bouzari S
Mol Immunol; 2018 Nov; 103():306-311. PubMed ID: 30343119
[TBL] [Abstract][Full Text] [Related]
16. Non-infectious outer membrane vesicles derived from Brucella abortus S19Δper as an alternative acellular vaccine protects mice against virulent challenge.
Solanki KS; Varshney R; Qureshi S; Thomas P; Singh R; Agrawal A; Chaudhuri P
Int Immunopharmacol; 2021 Jan; 90():107148. PubMed ID: 33189614
[TBL] [Abstract][Full Text] [Related]
17. Novel influenza virus vectors expressing Brucella L7/L12 or Omp16 proteins in cattle induced a strong T-cell immune response, as well as high protectiveness against B. abortus infection.
Tabynov K; Kydyrbayev Z; Ryskeldinova S; Yespembetov B; Zinina N; Assanzhanova N; Kozhamkulov Y; Inkarbekov D; Gotskina T; Sansyzbay A
Vaccine; 2014 Apr; 32(18):2034-41. PubMed ID: 24598723
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of a DNA vaccine containing an open reading frame with homology to an ABC-type transporter present in the genomic island 3 of Brucella abortus in BALB/c mice.
Riquelme-Neira R; Retamal-Díaz A; Acuña F; Riquelme P; Rivera A; Sáez D; Oñate A
Vaccine; 2013 Aug; 31(36):3663-7. PubMed ID: 23834811
[TBL] [Abstract][Full Text] [Related]
19. Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection.
Ghasemi A; Jeddi-Tehrani M; Mautner J; Salari MH; Zarnani AH
Vaccine; 2014 Nov; 32(49):6659-66. PubMed ID: 25240754
[TBL] [Abstract][Full Text] [Related]
20. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
Golshani M; Rafati S; Siadat SD; Nejati-Moheimani M; Shahcheraghi F; Arsang A; Bouzari S
Mol Immunol; 2015 Aug; 66(2):384-91. PubMed ID: 25968974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
